The efficacy of systemic staging for detection of distant metastases in newly diagnosed breast cancer and its impact on patient management: two breast units review on practice.
Association of Breast Surgery ePoster Library. Yip C. 05/13/19; 257124; P080
Ms. Christina Yip
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
P080
Topic: Diagnosis/ Referral
Introduction: Systemic staging for metastatic disease in newly diagnosed breast cancer is controversial; the detection yields is variable according to cancer stage and there is no consensus on which and how (CT +/- bone scan) patients should be staged. In two breast units in the West of Scotland, we routinely use CT (thorax, abdomen, pelvis) and isotope bone scan to stage women with ‘high risk' cancers.This study aims to review the diagnostic benefit of systemic staging and how it impacts patient management. Methods All patients with newly diagnosed breast cancer, in 2017, were identified from two West of Scotland breast surgery units database. Those who had pre-treatment systemic staging (CT and bone scan) were included in a separate database; indications and outcomes of their staging scans were recorded and evaluated. The management outcome of those with detected metastatic disease was reviewed. Results: 667 patients, age 30-88, had newly diagnosed breast cancer in 2017. 149 patients underwent systemic CT staging and 122 had bone scan. CT detected distant metastases were found in 28 patients. 36 patients had ‘hot spots' on their staging bone scans but only 8 were confirmed bony metastases, which all correlated to positive CT findings. All 28 patients received palliative hormonal/ radio- and chemotherapy.Conclusion Systemic staging revealed relatively low rate of occult metastatic disease. The CT detection of distance metastases guide palliative management. Our units will omit bone scan in the future, since it is of limited additional value to CT staging for bony metastases.
Topic: Diagnosis/ Referral
Introduction: Systemic staging for metastatic disease in newly diagnosed breast cancer is controversial; the detection yields is variable according to cancer stage and there is no consensus on which and how (CT +/- bone scan) patients should be staged. In two breast units in the West of Scotland, we routinely use CT (thorax, abdomen, pelvis) and isotope bone scan to stage women with ‘high risk' cancers.This study aims to review the diagnostic benefit of systemic staging and how it impacts patient management. Methods All patients with newly diagnosed breast cancer, in 2017, were identified from two West of Scotland breast surgery units database. Those who had pre-treatment systemic staging (CT and bone scan) were included in a separate database; indications and outcomes of their staging scans were recorded and evaluated. The management outcome of those with detected metastatic disease was reviewed. Results: 667 patients, age 30-88, had newly diagnosed breast cancer in 2017. 149 patients underwent systemic CT staging and 122 had bone scan. CT detected distant metastases were found in 28 patients. 36 patients had ‘hot spots' on their staging bone scans but only 8 were confirmed bony metastases, which all correlated to positive CT findings. All 28 patients received palliative hormonal/ radio- and chemotherapy.Conclusion Systemic staging revealed relatively low rate of occult metastatic disease. The CT detection of distance metastases guide palliative management. Our units will omit bone scan in the future, since it is of limited additional value to CT staging for bony metastases.
P080
Topic: Diagnosis/ Referral
Introduction: Systemic staging for metastatic disease in newly diagnosed breast cancer is controversial; the detection yields is variable according to cancer stage and there is no consensus on which and how (CT +/- bone scan) patients should be staged. In two breast units in the West of Scotland, we routinely use CT (thorax, abdomen, pelvis) and isotope bone scan to stage women with ‘high risk' cancers.This study aims to review the diagnostic benefit of systemic staging and how it impacts patient management. Methods All patients with newly diagnosed breast cancer, in 2017, were identified from two West of Scotland breast surgery units database. Those who had pre-treatment systemic staging (CT and bone scan) were included in a separate database; indications and outcomes of their staging scans were recorded and evaluated. The management outcome of those with detected metastatic disease was reviewed. Results: 667 patients, age 30-88, had newly diagnosed breast cancer in 2017. 149 patients underwent systemic CT staging and 122 had bone scan. CT detected distant metastases were found in 28 patients. 36 patients had ‘hot spots' on their staging bone scans but only 8 were confirmed bony metastases, which all correlated to positive CT findings. All 28 patients received palliative hormonal/ radio- and chemotherapy.Conclusion Systemic staging revealed relatively low rate of occult metastatic disease. The CT detection of distance metastases guide palliative management. Our units will omit bone scan in the future, since it is of limited additional value to CT staging for bony metastases.
Topic: Diagnosis/ Referral
Introduction: Systemic staging for metastatic disease in newly diagnosed breast cancer is controversial; the detection yields is variable according to cancer stage and there is no consensus on which and how (CT +/- bone scan) patients should be staged. In two breast units in the West of Scotland, we routinely use CT (thorax, abdomen, pelvis) and isotope bone scan to stage women with ‘high risk' cancers.This study aims to review the diagnostic benefit of systemic staging and how it impacts patient management. Methods All patients with newly diagnosed breast cancer, in 2017, were identified from two West of Scotland breast surgery units database. Those who had pre-treatment systemic staging (CT and bone scan) were included in a separate database; indications and outcomes of their staging scans were recorded and evaluated. The management outcome of those with detected metastatic disease was reviewed. Results: 667 patients, age 30-88, had newly diagnosed breast cancer in 2017. 149 patients underwent systemic CT staging and 122 had bone scan. CT detected distant metastases were found in 28 patients. 36 patients had ‘hot spots' on their staging bone scans but only 8 were confirmed bony metastases, which all correlated to positive CT findings. All 28 patients received palliative hormonal/ radio- and chemotherapy.Conclusion Systemic staging revealed relatively low rate of occult metastatic disease. The CT detection of distance metastases guide palliative management. Our units will omit bone scan in the future, since it is of limited additional value to CT staging for bony metastases.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}